CAS No. |
2227350-96-9 |
中文名称 |
4-[(S)-2-[(S)-2-氨基-3-甲基丁酰氨基]-5-脲基戊酰氨基]苄基(2-氧代-2-[(2S,4S)-2,5,12-三羟基-7-甲氧基-4-[[(1S,3R,4aS,9S,9aR,10aS)-9-甲氧基-1-甲基八氢-1H-吡喃并[4',3':4,5]噁唑并[2,3-c][1,4]噁嗪-3-基]氧基]-6,11-二氧代-1,2,3,4,6,11-六氢四苯-2-基]乙基)乙烷-1,2-二基双(甲基氨基甲酸酯) |
英文名称 |
4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl (2-oxo-2-((2S,4S)-2,5,12-trihydroxy-7-methoxy-4-(((1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl)oxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl) ethane-1,2-diylbis(methylcarbamate) |
别名 |
[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-4-[[(2S,4R,6S,7S,9R,10S)-10-methoxy-6-methyl-5,8,11-trioxa-1-azatricyclo[7.4.0.02,7]tridecan-4-yl]oxy]-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] N-[2-[[4-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methoxycarbonyl-methylamino]ethyl]-N-methylcarbamate;vc-PAB-DMEA-PNU159682 |
标准英文名 |
4-((S)-2-((S)-2-amino-3-methylbutanamido)-5-ureidopentanamido)benzyl (2-oxo-2-((2S,4S)-2,5,12-trihydroxy-7-methoxy-4-(((1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl)oxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl) ethane-1,2-diylbis(methylcarbamate) |
分子式 |
C56H72N8O19 |
分子量 |
1161.23
|
精确分子量 |
1160.49
|
SMILES |
OC1=C2C(C(C3=C(OC)C=CC=C3C2=O)=O)=C(O)C([C@H]4O[C@H]5C[C@]6([H])N7[C@]([C@H](OCC7)OC)([H])O[C@]6([H])[C@@H](O5)C)=C1C[C@](O)(C4)C(COC(N(C)CCN(C)C(OCC8=CC=C(C=C8)NC([C@H](CCCNC(N)=O)NC([C@@H](N)C(C)C)=O)=O)=O)=O)=O |
标准SMILES |
CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)NC1=CC=C(COC(=O)N(C)CCN(C)C(=O)OCC(=O)[C@@]2(O)C[C@H](O[C@H]3C[C@H]4[C@H](O[C@@H]5[C@H](OCCN45)OC)[C@H](C)O3)C3C(O)=C4C(=O)C5=C(C=CC=C5C(=O)C4=C(O)C=3C2)OC)C=C1 |
用途 |
vc-PAB-DMEA-PNU159682 (compound I.47) is used for the synthesis of antibody-drug conjugates (ADCs) based on sulfomaleimide-based linkers; it exhibits good serum stability. |
InChIKey |
BNWLMZKSKUNVSP-OLBIOUOSSA-N |